- Home
- CARM vs CLPS Comparison
CARM vs CLPS Comparison
Compare CARM & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARM
- CLPS
- Stock Information
- Founded
- CARM 2016
- CLPS 2005
- Country
- CARM United States
- CLPS Hong Kong
- Employees
- CARM N/A
- CLPS N/A
- Industry
- CARM Biotechnology: Pharmaceutical Preparations
- CLPS Computer Software: Prepackaged Software
- Sector
- CARM Health Care
- CLPS Technology
- Exchange
- CARM Nasdaq
- CLPS Nasdaq
- Market Cap
- CARM 41.5M
- CLPS 38.4M
- IPO Year
- CARM N/A
- CLPS 2018
- Fundamental
- Price
- CARM $0.94
- CLPS $1.09
- Analyst Decision
- CARM Strong Buy
- CLPS
- Analyst Count
- CARM 3
- CLPS 0
- Target Price
- CARM $12.67
- CLPS N/A
- AVG Volume (30 Days)
- CARM 183.3K
- CLPS 66.3K
- Earning Date
- CARM 11-07-2024
- CLPS 10-18-2024
- Dividend Yield
- CARM N/A
- CLPS 11.93%
- EPS Growth
- CARM N/A
- CLPS N/A
- EPS
- CARM N/A
- CLPS N/A
- Revenue
- CARM $20,268,000.00
- CLPS $142,812,726.00
- Revenue This Year
- CARM $50.40
- CLPS N/A
- Revenue Next Year
- CARM N/A
- CLPS N/A
- P/E Ratio
- CARM N/A
- CLPS N/A
- Revenue Growth
- CARM 41.13
- CLPS N/A
- 52 Week Low
- CARM $0.80
- CLPS $0.68
- 52 Week High
- CARM $3.16
- CLPS $1.70
- Technical
- Relative Strength Index (RSI)
- CARM 40.39
- CLPS 44.77
- Support Level
- CARM $0.96
- CLPS $1.02
- Resistance Level
- CARM $1.01
- CLPS $1.70
- Average True Range (ATR)
- CARM 0.06
- CLPS 0.13
- MACD
- CARM -0.01
- CLPS -0.04
- Stochastic Oscillator
- CARM 4.74
- CLPS 43.33
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting service, Customized IT solution service, and other. Generating majority of its revenue from the IT consulting service.